Generally, our research revealed the direct role of RBM47 in suppressing CC and modulating CXCL13 within TLS, emphasizing the significance of RBM47 in promoting anti-tumor immune responses and impeding tumor advancement. The gene discussed is CXCL13; the disease is neoplasm.